{
    "id": "MISSION500_2_1771344213459_CD",
    "itemType": "clozeDropdown",
    "difficulty": 5,
    "theme": "Safe and Effective Care Environment",
    "nclexClientNeed": "Reduction of Risk Potential",
    "integratedProcess": "Clinical Judgment",
    "cognitiveSkill": "Recognize Cues / Analyze Cues / Take Actions",
    "caseId": null,
    "kpis": [
        "Identifies contraindications for pharmacological therapies.",
        "Prioritizes nursing actions based on risk to client safety.",
        "Intervenes to prevent medication administration errors."
    ],
    "stem": "The nurse in the emergency department is reviewing the electronic health record (EHR) for a 68-year-old client diagnosed with an acute ischemic stroke. The stroke team has placed an order for Alteplase (tPA). The nurse must perform a final safety audit before administration.",
    "prompt": "Based on the client's data, complete the following sentences to articulate the priority nursing judgment.\n\nThe most critical finding that requires immediate re-evaluation of the treatment plan is the client's {{1}}. This data point represents an immediate and unacceptable risk for {{2}}. Therefore, the nurse's priority action is to {{3}}.",
    "tabs": [
        {
            "id": "tab1",
            "title": "Nurses' Notes",
            "content": "<b>Time 08:00:</b> Client arrived via EMS with acute onset of left-sided facial droop, slurred speech, and left arm weakness. Last known normal 06:00. Client is anxious, reports a \"pounding headache.\" History of hypertension (HTN) and T2DM. Reports running out of lisinopril 2 weeks ago; \"couldn't get an appointment.\" Client also reports having a lumbar puncture (LP) 5 days ago as part of a workup for persistent headaches."
        },
        {
            "id": "tab2",
            "title": "Vital Signs Trend",
            "content": "<ul><li><b>08:05:</b> BP: 208/116 mmHg, HR: 98, RR: 18, SpO2: 97% on room air, Temp: 37.1°C</li><li><b>08:20 (Post Labetalol 10 mg IV):</b> BP: 194/112 mmHg, HR: 92</li><li><b>08:35 (Post Labetalol 20 mg IV):</b> BP: 188/108 mmHg, HR: 88</li></ul>"
        },
        {
            "id": "tab3",
            "title": "Laboratory Results",
            "content": "<ul><li>Platelet Count: 195,000/mm³</li><li>INR: 1.0</li><li>aPTT: 29 seconds</li><li>Blood Glucose (POC): 224 mg/dL</li></ul>"
        },
        {
            "id": "tab4",
            "title": "Diagnostic Findings",
            "content": "<b>Non-Contrast Head CT (08:25):</b> No evidence of acute intracranial hemorrhage or mass effect. Subtle hypoattenuation noted in the right middle cerebral artery (MCA) territory, suggestive of early ischemia."
        },
        {
            "id": "tab5",
            "title": "MAR",
            "content": "<ul><li>Labetalol 10 mg IV Push @ 08:15</li><li>Labetalol 20 mg IV Push @ 08:30</li><li>Alteplase 72 mg IV infusion (0.9 mg/kg) - PENDING, AWAITING NURSE VERIFICATION</li></ul>"
        }
    ],
    "clozeOptions": [
        {
            "optionSetId": "1",
            "options": [
                {
                    "id": "opt1_1",
                    "text": "persistent severe hypertension"
                },
                {
                    "id": "opt1_2",
                    "text": "recent lumbar puncture"
                },
                {
                    "id": "opt1_3",
                    "text": "elevated blood glucose"
                },
                {
                    "id": "opt1_4",
                    "text": "early ischemic changes on CT"
                }
            ]
        },
        {
            "optionSetId": "2",
            "options": [
                {
                    "id": "opt2_1",
                    "text": "intracerebral hemorrhage"
                },
                {
                    "id": "opt2_2",
                    "text": "allergic reaction to the contrast dye"
                },
                {
                    "id": "opt2_3",
                    "text": "hypertensive encephalopathy"
                },
                {
                    "id": "opt2_4",
                    "text": "worsening of ischemic penumbra"
                }
            ]
        },
        {
            "optionSetId": "3",
            "options": [
                {
                    "id": "opt3_1",
                    "text": "administer the alteplase as ordered"
                },
                {
                    "id": "opt3_2",
                    "text": "withhold the alteplase and immediately notify the provider"
                },
                {
                    "id": "opt3_3",
                    "text": "request an order for a nicardipine infusion"
                },
                {
                    "id": "opt3_4",
                    "text": "prepare to administer subcutaneous insulin"
                }
            ]
        }
    ],
    "answer": [
        "opt1_1",
        "opt2_1",
        "opt3_2"
    ],
    "answerBreakdown": {
        "opt1_1": {
            "rationale": "Correct. The client's blood pressure remains 188/108 mmHg despite two doses of IV labetalol. Strict guidelines require a sustained blood pressure of less than 185/110 mmHg before and during tPA administration. This refractory hypertension is an absolute contraindication, as it dramatically increases the risk of hemorrhagic transformation.",
            "points": 1
        },
        "opt1_2": {
            "rationale": "Incorrect. A lumbar puncture within the last 7 days is a relative contraindication and warrants careful consideration. However, the persistent, severe hypertension is a more immediate and absolute contraindication that must be addressed first.",
            "points": 0
        },
        "opt1_3": {
            "rationale": "Incorrect. Hyperglycemia is common in acute stroke and should be managed, but it is not an absolute contraindication to tPA unless it is extremely severe (e.g., >400 mg/dL), and even then, management is prioritized alongside tPA.",
            "points": 0
        },
        "opt1_4": {
            "rationale": "Incorrect. The presence of early ischemic changes on a non-contrast head CT is the primary indication for administering tPA, not a contraindication. It confirms that the stroke is likely ischemic and not hemorrhagic.",
            "points": 0
        },
        "opt2_1": {
            "rationale": "Correct. The combination of fibrinolytic therapy (tPA) and severe hypertension creates immense pressure on cerebral blood vessels, making them highly susceptible to rupture. This leads to intracerebral hemorrhage, the most devastating complication of tPA therapy.",
            "points": 1
        },
        "opt2_2": {
            "rationale": "Incorrect. The diagnostic imaging was a non-contrast head CT, so no contrast dye was administered. This is not a relevant risk.",
            "points": 0
        },
        "opt2_3": {
            "rationale": "Incorrect. While the client's severe hypertension could lead to hypertensive encephalopathy, the specific risk related to administering tPA in this context is hemorrhage, not encephalopathy.",
            "points": 0
        },
        "opt2_4": {
            "rationale": "Incorrect. The goal of tPA is to salvage the ischemic penumbra (brain tissue at risk). The primary risk of administering tPA with severe hypertension is causing a bleed, not worsening the ischemia.",
            "points": 0
        },
        "opt3_1": {
            "rationale": "Incorrect. This is a dangerous action. Administering alteplase while the client's blood pressure is above the guideline threshold of 185/110 mmHg constitutes a serious medication error and places the client at high risk for a fatal intracranial bleed.",
            "points": 0
        },
        "opt3_2": {
            "rationale": "Correct. This is the critical 'SAFETY STOP' action. The nurse has identified an absolute contraindication. The immediate priority is to withhold the medication and communicate the finding to the provider. The provider must be informed that the blood pressure has not responded sufficiently to initial interventions and remains too high to safely proceed.",
            "points": 1
        },
        "opt3_3": {
            "rationale": "Incorrect. While a continuous infusion of an antihypertensive like nicardipine is a likely next step to manage the blood pressure, the nurse's first and most critical action is to halt the unsafe medication administration process and communicate the problem. Requesting the infusion is a subsequent collaborative action.",
            "points": 0
        },
        "opt3_4": {
            "rationale": "Incorrect. Managing the hyperglycemia is necessary but is not the priority over preventing a life-threatening intracerebral hemorrhage. The risk from the high blood pressure is immediate and catastrophic.",
            "points": 0
        }
    }
}